Weston Daniel

Company: EVOQ

Job title: Chief Development Officer

Seminars:

The NanoDisc Platform for Induction of Antigen- Specific Immune Tolerance 2:00 pm

Enabling disease-specific autoimmune therapy by lymph node and tolerogenic organ distribution Eliciting tolerizing dendritic cell signaling and bystander suppression Discussing applications to disease modelsRead more

day: Day 1 Treg Modulatorstrack

Industry Leader’s Fireside Chat: Comparing Treg Cell Therapies & Treg Modulators as Effective Treatments for Inflammatory & Autoimmune Diseases 8:30 am

Exploring the effectiveness of treatment personalization to direct the future of Treg therapies Discussing technological challenges in Treg cell therapy, Treg modulator and antigen-specific therapy development Comparing Treg cell therapy and modulator treatment efficacy to identify enhancements to progress Treg therapiesRead more

day: Conference Day One AM